These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3030570)

  • 1. Cardiac effects of menadione and its semiquinone.
    Carpenedo F; Floreani M; Santi Soncin E
    Cell Biol Int Rep; 1987 Jan; 11(1):63. PubMed ID: 3030570
    [No Abstract]   [Full Text] [Related]  

  • 2. New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase.
    Floreani M; Fossa P; Gessi S; Mosti L; Borea PA; Dorigo P
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):109-18. PubMed ID: 12595951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in calcium sensitivity of cardiac myofibrils contributes to the cardiotonic action of sulmazole.
    van Meel JC; Zimmermann R; Diederen W; Erdman E; Mrwa U
    Biochem Pharmacol; 1988 Jan; 37(2):213-20. PubMed ID: 2829914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
    Mushlin P; Boerth RC; Wells JN
    Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 2-methyl-1,4-naphthoquinone (menadione) on myocardial contractility and cardiac sarcoplasmic reticulum Ca-ATPase.
    Floreani M; Santi Soncin E; Carpenedo F
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):448-55. PubMed ID: 2472556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel class of cardiotonic agents: synthesis and biological evaluation of 5-substituted 3,6-dihydrothiadiazin-2-ones with cyclic AMP phosphodiesterase inhibiting and myofibrillar calcium sensitizing properties.
    Forest MC; Lahouratate P; Martin M; Nadler G; Quiniou MJ; Zimmermann RG
    J Med Chem; 1992 Jan; 35(1):163-72. PubMed ID: 1310113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
    Davis CW; Kuo JF
    Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of adenosine on cyclic AMP accumulation in ventricular myocardium.
    Huang M; Drummond GI
    Biochem Pharmacol; 1976 Dec; 25(24):2713-9. PubMed ID: 188424
    [No Abstract]   [Full Text] [Related]  

  • 10. Implication of cyclic AMP in the positive inotropic effects of cyclic GMP-inhibited cyclic AMP phosphodiesterase inhibitors on guinea pig isolated left atria.
    Muller B; Lugnier C; Stoclet JC
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):444-51. PubMed ID: 1691369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo myocardial effects of a cyclic AMP phosphodiesterase inhibitor structurally related to natural cardenolides.
    Prigent AF; Nemoz G; Roche M; Pacheco H
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):131-52. PubMed ID: 230791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction.
    Muller B; Lugnier C; Stoclet JC
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of cyclic AMP phosphodiesterase activity by ecarazine hydrochloride, hydralazine and their metabolites (author's transl)].
    Ishii A; Kubo K; Deguchi T; Tanaka M
    Yakugaku Zasshi; 1979 May; 99(5):533-6. PubMed ID: 232515
    [No Abstract]   [Full Text] [Related]  

  • 14. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
    Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
    Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity.
    Floreani M; Napoli E; Quintieri L; Palatini P
    Life Sci; 2003 May; 72(24):2741-50. PubMed ID: 12679191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One- and two-electron reduction of menadione in guinea-pig and rat cardiac tissue.
    Floreani M; Carpenedo F
    Gen Pharmacol; 1992 Jul; 23(4):757-62. PubMed ID: 1397983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthalenesulfonamides as calmodulin antagonists.
    Hidaka H; Tanaka T
    Methods Enzymol; 1983; 102():185-94. PubMed ID: 6139736
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic-AMP-dependent positive chrono- and inotropic responses in the blood-perfused dog atrium.
    Chiba S; Karasawa Y; Furukawa Y
    Adv Second Messenger Phosphoprotein Res; 1992; 25():363-72. PubMed ID: 1372814
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective action of cardiac DT-diaphorase against menadione toxicity in guinea pig isolated atria.
    Floreani M; Napoli E; Palatini P
    Biochem Pharmacol; 2000 Aug; 60(4):601-5. PubMed ID: 10874136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cAMP-phosphodiesterase inhibitors and tracheal smooth muscle relaxation.
    Newman DJ; Colella DF; Spainhour CB; Brann EG; Zabko-Potapovich B; Wardell JR
    Biochem Pharmacol; 1978 Mar; 27(5):729-32. PubMed ID: 207279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.